Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.
Identifieur interne : 004618 ( PubMed/Corpus ); précédent : 004617; suivant : 004619Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.
Auteurs : E. Perucca ; E. Marchioni ; D. Soragna ; F. SavoldiSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1997.
English descriptors
- KwdEn :
- Aged, Cytochrome P-450 CYP2D6 (metabolism), Drug Interactions, Dyskinesia, Drug-Induced (enzymology), Female, Fluoxetine (adverse effects), Fluoxetine (pharmacokinetics), Humans, Psychotropic Drugs (adverse effects), Serotonin Uptake Inhibitors (adverse effects), Serotonin Uptake Inhibitors (pharmacokinetics).
- MESH :
- chemical , adverse effects : Fluoxetine, Psychotropic Drugs, Serotonin Uptake Inhibitors.
- chemical , metabolism : Cytochrome P-450 CYP2D6.
- enzymology : Dyskinesia, Drug-Induced.
- chemical , pharmacokinetics : Fluoxetine, Serotonin Uptake Inhibitors.
- Aged, Drug Interactions, Female, Humans.
DOI: 10.1002/mds.870120432
PubMed: 9251094
Links to Exploration step
pubmed:9251094Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.</title>
<author><name sortKey="Perucca, E" sort="Perucca, E" uniqKey="Perucca E" first="E" last="Perucca">E. Perucca</name>
</author>
<author><name sortKey="Marchioni, E" sort="Marchioni, E" uniqKey="Marchioni E" first="E" last="Marchioni">E. Marchioni</name>
</author>
<author><name sortKey="Soragna, D" sort="Soragna, D" uniqKey="Soragna D" first="D" last="Soragna">D. Soragna</name>
</author>
<author><name sortKey="Savoldi, F" sort="Savoldi, F" uniqKey="Savoldi F" first="F" last="Savoldi">F. Savoldi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9251094</idno>
<idno type="pmid">9251094</idno>
<idno type="doi">10.1002/mds.870120432</idno>
<idno type="wicri:Area/PubMed/Corpus">004618</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.</title>
<author><name sortKey="Perucca, E" sort="Perucca, E" uniqKey="Perucca E" first="E" last="Perucca">E. Perucca</name>
</author>
<author><name sortKey="Marchioni, E" sort="Marchioni, E" uniqKey="Marchioni E" first="E" last="Marchioni">E. Marchioni</name>
</author>
<author><name sortKey="Soragna, D" sort="Soragna, D" uniqKey="Soragna D" first="D" last="Soragna">D. Soragna</name>
</author>
<author><name sortKey="Savoldi, F" sort="Savoldi, F" uniqKey="Savoldi F" first="F" last="Savoldi">F. Savoldi</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Cytochrome P-450 CYP2D6 (metabolism)</term>
<term>Drug Interactions</term>
<term>Dyskinesia, Drug-Induced (enzymology)</term>
<term>Female</term>
<term>Fluoxetine (adverse effects)</term>
<term>Fluoxetine (pharmacokinetics)</term>
<term>Humans</term>
<term>Psychotropic Drugs (adverse effects)</term>
<term>Serotonin Uptake Inhibitors (adverse effects)</term>
<term>Serotonin Uptake Inhibitors (pharmacokinetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Fluoxetine</term>
<term>Psychotropic Drugs</term>
<term>Serotonin Uptake Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cytochrome P-450 CYP2D6</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Fluoxetine</term>
<term>Serotonin Uptake Inhibitors</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Drug Interactions</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">9251094</PMID>
<DateCreated><Year>1997</Year>
<Month>10</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>1997</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>12</Volume>
<Issue>4</Issue>
<PubDate><Year>1997</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.</ArticleTitle>
<Pagination><MedlinePgn>624-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perucca</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Marchioni</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Soragna</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Savoldi</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>01K63SUP8D</RegistryNumber>
<NameOfSubstance UI="D005473">Fluoxetine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.14.14.1</RegistryNumber>
<NameOfSubstance UI="D019389">Cytochrome P-450 CYP2D6</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Mov Disord. 1996 May;11(3):324-6</RefSource>
<PMID Version="1">8723152</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019389">Cytochrome P-450 CYP2D6</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004347">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004409">Dyskinesia, Drug-Induced</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005473">Fluoxetine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000493">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011619">Psychotropic Drugs</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D017367">Serotonin Uptake Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000493">pharmacokinetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year>
<Month>7</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1997</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1997</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">9251094</ArticleId>
<ArticleId IdType="doi">10.1002/mds.870120432</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004618 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004618 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:9251094 |texte= Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:9251094" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |